Biomarkers in Brain Disease, Volume 1180

1. The Uses of Biomarkers in Drug Development (Orest Hurko).

2. Biomarkers, Dementia, and Public Health (C.F. Wright, A. Hall A, F.E. Matthews, and C. Brayne).

3. Imaging Biomarkers in Alzheimer's Disease (Natalie Ryan and Nick C. Fox).

4. CSF Biomarkers: Pin-pointing Alzheimer pathogenesis (Niklas Mattsson, Kaj Blennow, and Henrik Zetterberg).

5. AddNeuroMed: The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease (Simon Lovestone, Paul Francis, Iwona Kloszewska, Patrizia Mecocci, Andrew Simmons, Hilkka Soininen, Christian Spenger, Magda Tsolaki, Bruno Vellas, Lars-Olof Wahlund, Malcolm Ward, on behalf of the AddNeuroMed consortium).

6. MRI Measures of Alzheimer's Disease and the AddNeuroMed Study (Andrew Simmons, Eric Westman, Sebastian Muehlboeck, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kloszewska, Lars-Olof Wahlund, Hilkka Soininen, Simon Lovestone, Alan Evans, Christian Spenger, for the AddNeuroMed consortium).

7. Identifying Early Markers of Alzheimer's disease using Quantitative Multiplex Proteomic Immunoassay Panels (Holly D. Soares, Yu Chen, Marwin Sabbagh, Alex Rohrer, Elisabeth Schrijvers, and Monique Breteler).

8. Proteomics for Brain Disorders: The Promise for Biomarkers (Malcolm Ward, Andreas Güntert, James Campbell, and Ian Pi).

9. Use of Genetic Variation as Biomarkers for Alzheimer's disease (Christiane Reitz and Richard Mayeux).

10. Biomarkers in Huntington's and Parkinson's Disease (Gráinne C. O'Keeffe, Andrew W. Michell, Roger A. Barker).

11. Biomarkers in Oncology (Trials and Tribulations: Sheila E. Taube).

12. Biomarkers in Alzheimer's Disease: Not Yet Surrogate Endpoints (N. Coley, S. Andrieu, J. Delrieu, T. Voisin, and B. Vellas).